top of page

Cybersecurity in pharma: Securing the future

“A major challenge is that cyber literacy needs to improve in the pharmaceutical space,” adds Charles Fracchia, BIO-ISAC Cofounder and Board Chair. “Right now, it’s compliance by checkbox, in a static way. While it is unreasonable to expect the level of security in the nuclear sector, we should have checks and balances at every step, creating a new level of assurance. Regulators need to work together with industry to certify hot patches to quickly fix vulnerabilities while maintaining pharmaceutical quality." Read more:


Commenting has been turned off.
bottom of page